Among the latter, a nested case-control study of 88 patients with primary invasive epithelial OC compared to 168 matched, cancer-free control women showed that FSH levels were not significantly different between women who were subsequently diagnosed with OC and control women. This evidence concerns the gene BRD2 and cancer.